Association of admission frailty and frailty changes during cardiac rehabilitation with 5-year outcomes.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
12 07 2023
Historique:
received: 24 11 2022
revised: 11 02 2023
accepted: 15 02 2023
pmc-release: 17 02 2024
medline: 13 7 2023
pubmed: 18 2 2023
entrez: 17 2 2023
Statut: ppublish

Résumé

Examine the association between (1) admission frailty and (2) frailty changes during cardiac rehabilitation (CR) with 5-year outcomes (i.e. time to mortality, first hospitalization, first emergency department (ED) visit, and number of hospitalizations, hospital days, and ED visits). Data from patients admitted to a 12-week CR programme in Halifax, Nova Scotia, from May 2005 to April 2015 (n = 3371) were analysed. A 25-item frailty index (FI) estimated frailty levels at CR admission and completion. FI improvements were determined by calculating the difference between admission and discharge FI. CR data were linked to administrative health data to examine 5-year outcomes [due to all causes and cardiovascular diseases (CVDs)]. Cox regression, Fine-Gray models, and negative binomial hurdle models were used to determine the association between FI and outcomes. On average, patients were 61.9 (SD: 10.7) years old and 74% were male. Mean admission FI scores were 0.34 (SD: 0.13), which improved by 0.07 (SD: 0.09) by CR completion. Admission FI was associated with time to mortality [HRs/IRRs per 0.01 FI increase: all causes = 1.02(95% CI 1.01,1.04); CVD = 1.03(1.02,1.05)], hospitalization [all causes = 1.02(1.01,1.02); CVD = 1.02(1.01,1.02)], ED visit [all causes = 1.01(1.00,1.01)], and the number of hospitalizations [all causes = 1.02(95% CI 1.01,1.03); CVD = 1.02(1.00,1.04)], hospital days [all causes = 1.01(1.01,1.03)], and ED visits [all causes = 1.02(1.02,1.03)]. FI improvements during CR had a protective effect regarding time to all-cause hospitalization [0.99(0.98,0.99)] but were not associated with other outcomes. Frailty status at CR admission was related to long-term adverse outcomes. Frailty improvements during CR were associated with delayed all-cause hospitalization, in which a larger effect was associated with a greater chance of improved outcome. This work improves our understanding of the relationship between admission frailty and frailty changes with mortality, hospitalization, and emergency department (ED) use in a cardiac rehabilitation (CR) setting. Frailty changes during CR were related with time to hospitalization due to any cause.Higher frailty levels at admission of CR were related to lower time to death, re-hospitalization, and ED visit and to a higher total number of hospitalizations and ED visits due to all causes or due to cardiovascular diseases.Overall, this work underscores the importance of considering the degree of frailty in the CR setting for the purpose of predicting adverse outcomes.

Autres résumés

Type: plain-language-summary (eng)
This work improves our understanding of the relationship between admission frailty and frailty changes with mortality, hospitalization, and emergency department (ED) use in a cardiac rehabilitation (CR) setting. Frailty changes during CR were related with time to hospitalization due to any cause.Higher frailty levels at admission of CR were related to lower time to death, re-hospitalization, and ED visit and to a higher total number of hospitalizations and ED visits due to all causes or due to cardiovascular diseases.Overall, this work underscores the importance of considering the degree of frailty in the CR setting for the purpose of predicting adverse outcomes.

Identifiants

pubmed: 36799963
pii: 7044709
doi: 10.1093/eurjpc/zwad048
pmc: PMC10335868
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

807-819

Subventions

Organisme : CIHR
Pays : Canada

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Conflict of interest: J.Q., D.S.K., N.G., C.M., C.B., OT, and W.F.: none; K.R. has asserted copyright of the Clinical Frailty Scale through Dalhousie University’s Industry, Liaison, and Innovation Office. Use is free for education, research, and not-for-profit health care. Users agree not to change or commercialize the scale. In addition to academic and hospital appointments, K.R. is cofounder of Ardea Outcomes, which (as DGI Clinical) in the last 3 years has contracts with pharma and device manufacturers (Biogen, Hollister, INmune, Novartis, Nutricia, and Takeda) on individualized outcome measurement. In 2019, K.R. was paid an honorarium for an interview with Biogen. In 2020, he attended an advisory board meeting with Nutricia on dementia and chaired a scientific workshop and technical review panel on frailty for the Singapore National Research Foundation. Otherwise, any personal fees were for invited guest lectures, rounds, and academic symposia, received directly from event organizers for presentations on frailty. K.R. is an associate director of the Canadian Consortium on Neurodegeneration in Aging, which is funded by the Canadian Institutes for Health Research, the Alzheimer Society of Canada, and several other charities.

Références

J Gerontol A Biol Sci Med Sci. 2021 Aug 13;76(9):1619-1626
pubmed: 33103718
Clin Interv Aging. 2017 Aug 08;12:1239-1249
pubmed: 28848332
Am J Cardiol. 2009 Jun 1;103(11):1616-21
pubmed: 19463525
J Am Geriatr Soc. 2016 Feb;64(2):285-92
pubmed: 26889838
J Am Geriatr Soc. 2019 Nov;67(11):2311-2317
pubmed: 31317527
Heart. 2016 Sep 15;102(18):1449-55
pubmed: 27181874
Heart. 2019 Apr;105(7):510-515
pubmed: 30700518
BMC Med. 2014 Oct 07;12:171
pubmed: 25288274
Circulation. 2022 Jul 12;146(2):80-90
pubmed: 35616018
J Frailty Aging. 2012;1(1):8-12
pubmed: 27092931
J Nutr Health Aging. 2021;25(2):155-159
pubmed: 33491028
Eur J Prev Cardiol. 2022 Aug 5;29(10):1412-1424
pubmed: 35167666
Can J Cardiol. 2009 Jun;25(6):e195-202
pubmed: 19536390
Age Ageing. 2022 Feb 2;51(2):
pubmed: 35180287
Stat Med. 2017 Nov 30;36(27):4391-4400
pubmed: 28913837
J Cardiopulm Rehabil Prev. 2020 Sep;40(5):310-318
pubmed: 32804797
Gen Thorac Cardiovasc Surg. 2019 Nov;67(11):917-924
pubmed: 30953315
Nat Aging. 2021 Aug;1(8):651-665
pubmed: 37117769
J Am Coll Cardiol. 2022 Sep 20;80(12):1144-1146
pubmed: 36050228
J Cardiopulm Rehabil Prev. 2020 Mar;40(2):79-86
pubmed: 31764535
BMC Geriatr. 2021 Dec 18;21(1):726
pubmed: 34922488
Cardiol Res. 2020 Dec;11(6):405-411
pubmed: 33224387
PLoS One. 2015 Feb 06;10(2):e0116256
pubmed: 25659147
Eur J Prev Cardiol. 2017 Apr;24(6):577-590
pubmed: 27940954
CMAJ. 2011 May 17;183(8):E487-94
pubmed: 21540166
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):230-8
pubmed: 27166209
Age Ageing. 2017 May 1;46(3):401-407
pubmed: 28064172
Periodontol 2000. 2016 Oct;72(1):13-8
pubmed: 27501488
Cardiol Res. 2021 Jun;12(3):169-176
pubmed: 34046111
Health Serv Res. 2017 Jun;52(3):1168-1184
pubmed: 27319798
Am J Med. 2015 Nov;128(11):1225-1236.e1
pubmed: 26159634
J Am Coll Cardiol. 2011 May 3;57(18):1801-10
pubmed: 21527153
Nature. 2018 Sep;561(7721):45-56
pubmed: 30185958
Geriatr Gerontol Int. 2019 Apr;19(4):287-292
pubmed: 30793829
Ageing Res Rev. 2013 Mar;12(2):719-36
pubmed: 22426304
BMC Geriatr. 2012 Sep 25;12:58
pubmed: 23009149
J Am Med Dir Assoc. 2016 May 1;17(5):426-33
pubmed: 26947059
Can J Cardiol. 2006 Sep;22(11):905-11
pubmed: 16971975
J Gerontol A Biol Sci Med Sci. 2020 Sep 25;75(10):1928-1934
pubmed: 32274501
Int Heart J. 2020 May 30;61(3):571-578
pubmed: 32418965
J Cardiol. 2021 Apr;77(4):424-431
pubmed: 33288376
J Gerontol A Biol Sci Med Sci. 2020 May 22;75(6):1143-1147
pubmed: 32145016
Eur Heart J. 2006 Jul;27(13):1610-9
pubmed: 16495286
Eur J Prev Cardiol. 2023 Jan 24;30(2):149-166
pubmed: 36098041
J Cardiol. 2020 Jun;75(6):587-593
pubmed: 31899114
Cochrane Database Syst Rev. 2017 Jun 30;6:CD007130
pubmed: 28665511
J Am Geriatr Soc. 2021 Apr;69(4):1057-1062
pubmed: 33377190
J Am Geriatr Soc. 2021 Sep;69(9):2476-2485
pubmed: 33826158
BMC Geriatr. 2008 Sep 30;8:24
pubmed: 18826625
Can J Cardiol. 2020 Apr;36(4):482-489
pubmed: 31837892
J Am Geriatr Soc. 2008 Sep;56(9):1651-7
pubmed: 18691282
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
J Aging Res. 2011 Apr 04;2011:569194
pubmed: 21584244
Circ Heart Fail. 2020 Oct;13(10):e006798
pubmed: 32986957
CMAJ Open. 2020 Dec 1;8(4):E796-E809
pubmed: 33262118
Eur J Prev Cardiol. 2022 Feb 19;29(1):216-227
pubmed: 34270717
Ageing Res Rev. 2017 May;35:63-73
pubmed: 28143778

Auteurs

Jack Quach (J)

School of Physiotherapy, Dalhousie University, 5869 University Ave, Halifax, NS B3H 4R2, Canada.
Division of Geriatric Medicine, Dalhousie University, 5955 Veterans Memorial Lane, Halifax, NS B3H 2E1, Canada.

Dustin Scott Kehler (DS)

School of Physiotherapy, Dalhousie University, 5869 University Ave, Halifax, NS B3H 4R2, Canada.
Division of Geriatric Medicine, Dalhousie University, 5955 Veterans Memorial Lane, Halifax, NS B3H 2E1, Canada.

Nicholas Giacomantonio (N)

Division of Cardiology, Dalhousie University, 1796 Summer Street, Halifax, NS B3H 3A7, Canada.
Department of Medicine, Dalhousie University, 1276 South Park Street, Halifax, NS B3H 2Y9, Canada.

Caitlin McArthur (C)

School of Physiotherapy, Dalhousie University, 5869 University Ave, Halifax, NS B3H 4R2, Canada.

Chris Blanchard (C)

Department of Medicine, Dalhousie University, 1276 South Park Street, Halifax, NS B3H 2Y9, Canada.

Wanda Firth (W)

Queen Elizabeth II Health Sciences Centre, Heart Health, 1276 South Park St, Halifax, NS B3H 2Y9, Canada.

Kenneth Rockwood (K)

Division of Geriatric Medicine, Dalhousie University, 5955 Veterans Memorial Lane, Halifax, NS B3H 2E1, Canada.

Olga Theou (O)

School of Physiotherapy, Dalhousie University, 5869 University Ave, Halifax, NS B3H 4R2, Canada.
Division of Geriatric Medicine, Dalhousie University, 5955 Veterans Memorial Lane, Halifax, NS B3H 2E1, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH